Slow Walking Speed May Signal Onset of Alzheimer's
the Psychiatry Advisor take:
The gait of an older adult may be an indicator of whether or not they develop Alzheimer’s disease later on.
Natalia del Campo, PhD, of Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, France, and colleagues examined 128 people, average age of 76 years old, without dementia but considered at high risk for it due to memory problems. Positron emission tomography scans were conducted on their brains, and 48% of participants had level of beta-amyloid at levels high enough to be associated with dementia.
Researchers also tested the subjects’ thinking and memory skills, as well as their ability to complete everyday tasks. Mild cognitive impairment was found in 46% of them.
The participants’ walking speed was also measured. There was a link between slow walking and speed and amyloid levels in certain areas of the brain, including one responsible for motor functions, the researchers reported in the journal Neurology.
After comparing the speed people walked with and without accounting for amyloid amounts, the researchers found up to 9% of the difference were the result of amyloid levels. However, the connection between amyloid and walking speed was not altered when accounting for age, education, or extent of memory problems.
“It’s possible that having subtle walking disturbances in addition to memory concerns may signal Alzheimer's disease, even before people show any clinical symptoms,” del Campo said in a statement.
Researchers found a link between slow walking and speed and amyloid levels in certain areas of the brain.
The speed at which elderly people walk may indicate their likelihood of developing Alzheimer's disease, according to research published in Neurology.
Researchers led by Natalia del Campo, PhD, of the Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, in France, hypothesized that a slower speed of walking may be related to the amount of amyloid plaque people with Alzheimer's have built up in their brains, even if they do not yet have external symptoms of Alzheimer's disease.
Amyloid precursor protein (APP) occurs throughout the body. The amyloid hypothesis proposes that there is a fault with the processing of APP in the brain, leading to the production of a short fragment of APP, a sticky protein known as beta-amyloid.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Should Physicians Treat Family and Friends? Three Experts Weigh In
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Influence of Psychostimulants on BMI and Height in Youth With ADHD
- Medication Adherence Predictors in Patients With Severe Psychiatric Disorders
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Have You Experienced an Ethical Conundrum Regarding Involuntary Commitment of a Patient?
- Functional Restoration for Chronic Pain and Depression in the Elderly: Pharmacotherapy and Beyond
- Efficacy of Long-Acting Injectable Antipsychotics vs Oral Antipsychotics
- Older Age Associated With Worse Major Depressive Disorder Outcomes
- Preoperative Psychiatric Diagnoses Not Associated With Bariatric Surgery Outcomes
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations